Urinary elimination kinetics of pyrimethamine. 2009

J B Mouankie, and W Senczuk, and E Florek
Faculty of Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.

In this study, the kinetics of pyrimethamine elimination via the urine was investigated. The experiments were carried out on six healthy male volunteers aged 23-32 years. The drug was administered orally (p.o.) in a single dose at three different concentrations i.e.: 50, 75 and 100 mg. The concentration of the drug in the urine was determined via the modified method of Bonini et al. and Garber et al. It was found that 13.4 +/- 1.3% of the dose eliminated via the urine was in unchanged form. The process of pyrimethamine elimination may be described according to an open kinetic two-compartmental model: the formula showing the course of pyrimethamine elimination over time has been given. Several examples of the quantitative exposure test have been proposed, which allow the calculation of the drug dose absorbed and thus the degree of toxicity to be determined. This test can also be useful in a controlled clinical setting.

UI MeSH Term Description Entries
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

J B Mouankie, and W Senczuk, and E Florek
January 1981, British journal of clinical pharmacology,
J B Mouankie, and W Senczuk, and E Florek
January 1984, Developmental pharmacology and therapeutics,
J B Mouankie, and W Senczuk, and E Florek
December 1981, Toxicology letters,
J B Mouankie, and W Senczuk, and E Florek
October 2006, Toxicological sciences : an official journal of the Society of Toxicology,
J B Mouankie, and W Senczuk, and E Florek
May 1988, Pharmacology & toxicology,
J B Mouankie, and W Senczuk, and E Florek
October 1982, Fortschritte der Medizin,
J B Mouankie, and W Senczuk, and E Florek
January 1982, Developmental pharmacology and therapeutics,
J B Mouankie, and W Senczuk, and E Florek
June 1977, Clinical pharmacology and therapeutics,
J B Mouankie, and W Senczuk, and E Florek
January 1971, Arhiv za higijenu rada i toksikologiju,
J B Mouankie, and W Senczuk, and E Florek
December 1954, Acta physiologica Scandinavica,
Copied contents to your clipboard!